(Q38077590)

English

The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes

scientific article published on May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

multiple sclerosis

0 references

inflammasome complex

1 reference

based on heuristic

inferred from title

author name string

Makoto Inoue

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Mari L Shinohara

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

139

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

11-18

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Pyroptosis - a cell death modality of its kind?

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Pyroptosis: host cell death and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Emerging inflammasome effector mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Cryopyrin activates the inflammasome in response to toxins and ATP

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The inflammasomes

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

ATP binding by monarch-1/NLRP12 is critical for its inhibitory function

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Non-canonical inflammasome activation targets caspase-11

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Caspase-1 expression in multiple sclerosis plaques and cultured glial cells

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Increased expression and function of glutamate transporters in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

T-bet-dependent expression of osteopontin contributes to T cell polarization

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

IFN-beta inhibits human Th17 cell differentiation

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Toll-like receptor (TLR) and inflammasome actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Immunologic therapy of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Serum uric acid levels in patients with multiple sclerosis: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634535

16 September 2018

IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634535

17 October 2018

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Polimorphisms in Inflammasome Genes Are Involved in the Predisposition to Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FIMM.12081

21 January 2018

Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cathepsin B activity in multiple sclerosis brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: nitric oxide inhibits the NLRP3 inflammasome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23360426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/IMM.12081

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38077590&oldid=1740318971"